US 12123001
Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 12123001 (Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61K45/06, A61P